Skip to main content
. Author manuscript; available in PMC: 2020 Jan 6.
Published in final edited form as: J Am Acad Child Adolesc Psychiatry. 2016 Aug 4;55(10):851–859.e2. doi: 10.1016/j.jaac.2016.07.768

Figure 3.

Figure 3

Clomipramine response in obsessive-compulsive disorder (OCD). Note: Differences in Children's Yale-Brown Obsessive-Compulsive Scale (CY-BOCS) ratings across time between patients treated with clomipramine and placebo. A) Weighted mean difference in CY-BOCS between clomipramine and placebo at time points. Error bars represent standard error. B) Best-fit model (logarithmically decreasing treatment response) for the weighted mean difference between groups. Dotted lines represent 95% CIs. These figures are based on data from 2 studies involving 76 participants.